Equity
€1.4m ▲ 17.9%
Dr. Ann Verschelde has made a profit in every financial year since 2010.
Dr. Ann Verschelde
Lifetime
15 annual accounts with figures on one time axispeak €368,852 (2010)
€302,763▲ 12.6%
peak €212,177 (2025)
€212,177▲ 13.4%
peak €1.4m (2025)
€1.4m▲ 17.9%
€3,971▲ 15×
Board1 name since 2008
1 director
Documentsfilings and deeds
10-03-202621 days before the deadline
2025micro format
Gross margin from €268,953 to €302,763Equity from €1.2m to €1.4mDebts from €264 to €3,971
Key points
from the 2025 annual accountsFilings
15 annual accounts since 2010
The last five annual accounts were filed 0 to 31 days before the end of the period.
Position in the sector
99.7%
Higher solvency than 95% of companies in human health. Sector median 63.1% · 21,322 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 17,811 companies had the same profile as Dr. Ann Verschelde has now. Each dot stands for 45 companies, two years later.
96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 17,811 companies, not a prediction for Dr. Ann Verschelde. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0807112452
Resignation: (director)
Reappointment: (director) · Director discharge: · General meeting of 05-10-2022 · Gazette deed
Capital decrease of €297,297.62 to €18,550
Capital from €315,847.62 to €18,550 · General meeting of 21-12-2017 · Gazette deed
Incorporation
published on 17-10-2008 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Dr. Ann Verschelde Ostend | €1.4m | €302,763 | 99.7% | - |
| Dr. F. Stockmans Kortrijk | €1.3m | €283,824 | 76.9% | - |
| DOKTER DANIELLA SMOLDERS Koksijde | €1.4m | €294,607 | 44.1% | - |
| Dr. Raetschelders Menen | €1.3m | €292,980 | 29.0% | - |
| Fran Care Kortrijk | €1.5m | €320,716 | 98.1% | - |
| ORTHODONTIEPRAKTIJK KATHLEEN GUNST Torhout | €1.6m | €299,036 | 51.8% | - |
| Dokter E. Suys Kortrijk | €1.6m | €311,844 | 95.9% | - |
These companies have the same main activity as Dr. Ann Verschelde: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.3m and €1.6m, founded between 2006 and 2010.
Official details
Source: KBO- Status
- Active since 15-10-2008Normal situation
- Activity
- Specialist medical practiceNACE 86220and 1 other
- Establishment units
- 2.271.800.7728400 Ostend, since 15-10-2008
- 2.271.801.1688400 Ostend, since 15-10-2008
- Financial year end
- 31 August
- Peppol
- Reachable since 21-09-2025
Annual accounts to 31-08-2025
- ≈ €460,000estimated
- €1.4m▲ 18.2%
- Filing
- Filed on 10-03-2026, 21 days before the end of the filing period
Insights on Dr. Ann Verschelde
Dr. Ann Verschelde files the micro format. That format states no turnover. The gross margin fell from €368,852 in 2010 to €302,763 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Dr. Ann Verschelde
- What is the company number of Dr. Ann Verschelde?
- The company number of Dr. Ann Verschelde is 0807.112.452. The VAT number is the same number with BE in front: BE 0807.112.452.
- Where is Dr. Ann Verschelde based?
- The registered office is at Stockholmstraat 25, 8400 Ostend.Company details
- What does Dr. Ann Verschelde do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of Dr. Ann Verschelde?
- Dr. Ann Verschelde is a private limited company (BV).
- When was Dr. Ann Verschelde founded?
- Dr. Ann Verschelde was founded on 15-10-2008.
- Is Dr. Ann Verschelde still active?
- Yes, Dr. Ann Verschelde is an active enterprise in the KBO register.
- What is the turnover of Dr. Ann Verschelde?
- The turnover in financial year 2025 is ≈ €460,000. This figure is estimated from the gross margin of €302,763 and 31 comparable companies (NACE 86220). It probably lies between €400,000 and €630,000.Financials
- Is Dr. Ann Verschelde profitable?
- In financial year 2025, Dr. Ann Verschelde made a profit of €212,177.
- Where can I find the annual accounts of Dr. Ann Verschelde?
- Dr. Ann Verschelde filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Dr. Ann Verschelde due?
- Dr. Ann Verschelde must file the annual accounts for financial year 2026 by 31-03-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.